Newman-Tancredi A - Search Results

1

S33005, a novel ligand at both serotonin and norepinephrine transporters: I. Receptor binding, electrophysiological, and neurochemical profile in comparison with venlafaxine, reboxetine, citalopram, and clomipramine.

Millan MJ, Gobert A, Lejeune F, Newman-Tancredi A, Rivet JM, Auclair A, Peglion JL. Millan MJ, et al. J Pharmacol Exp Ther. 2001 Aug;298(2):565-80. J Pharmacol Exp Ther. 2001. PMID: 11454918

2

Differential actions of antiparkinson agents at multiple classes of monoaminergic receptor. I. A multivariate analysis of the binding profiles of 14 drugs at 21 native and cloned human receptor subtypes.

Millan MJ, Maiofiss L, Cussac D, Audinot V, Boutin JA, Newman-Tancredi A. Millan MJ, et al. J Pharmacol Exp Ther. 2002 Nov;303(2):791-804. doi: 10.1124/jpet.102.039867. J Pharmacol Exp Ther. 2002. PMID: 12388666

3

Differential actions of antiparkinson agents at multiple classes of monoaminergic receptor. III. Agonist and antagonist properties at serotonin, 5-HT(1) and 5-HT(2), receptor subtypes.

Newman-Tancredi A, Cussac D, Quentric Y, Touzard M, Verrièle L, Carpentier N, Millan MJ. Newman-Tancredi A, et al. J Pharmacol Exp Ther. 2002 Nov;303(2):815-22. doi: 10.1124/jpet.102.039883. J Pharmacol Exp Ther. 2002. PMID: 12388668

4

S32504, a novel naphtoxazine agonist at dopamine D3/D2 receptors: I. Cellular, electrophysiological, and neurochemical profile in comparison with ropinirole.

Millan MJ, Cussac D, Gobert A, Lejeune F, Rivet JM, Mannoury La Cour C, Newman-Tancredi A, Peglion JL. Millan MJ, et al. J Pharmacol Exp Ther. 2004 Jun;309(3):903-20. doi: 10.1124/jpet.103.062398. Epub 2004 Feb 20. J Pharmacol Exp Ther. 2004. PMID: 14978194

5

Functional correlates of dopamine D3 receptor activation in the rat in vivo and their modulation by the selective antagonist, (+)-S 14297: 1. Activation of postsynaptic D3 receptors mediates hypothermia, whereas blockade of D2 receptors elicits prolactin secretion and catalepsy.

Millan MJ, Peglion JL, Vian J, Rivet JM, Brocco M, Gobert A, Newman-Tancredi A, Dacquet C, Bervoets K, Girardon S, et al. Millan MJ, et al. J Pharmacol Exp Ther. 1995 Nov;275(2):885-98. J Pharmacol Exp Ther. 1995. PMID: 7473180

6

Modulation of the activity of central serotoninergic neurons by novel serotonin1A receptor agonists and antagonists: a comparison to adrenergic and dopaminergic neurons in rats.

Gobert A, Lejeune F, Rivet JM, Audinot V, Newman-Tancredi A, Millan MJ. Gobert A, et al. J Pharmacol Exp Ther. 1995 Jun;273(3):1032-46. J Pharmacol Exp Ther. 1995. PMID: 7791073

7

Antagonist properties of LY 165,163 at pre- and postsynaptic dopamine D2, D3 and D1 receptors: modulation of agonist actions at 5-HT1A receptors in vivo.

Millan MJ, Rivet JM, Audinot V, Gobert A, Lejeune F, Brocco M, Newman-Tancredi A, Maurel-Remy S, Bervoets K. Millan MJ, et al. J Pharmacol Exp Ther. 1995 Jun;273(3):1418-27. J Pharmacol Exp Ther. 1995. PMID: 7791116

8

Interactions of (+)- and (-)-8- and 7-hydroxy-2-(di-n-propylamino)tetralin at human (h)D3, hD2 and h serotonin1A receptors and their modulation of the activity of serotoninergic and dopaminergic neurones in rats.

Lejeune F, Newman-Tancredi A, Audinot V, Millan MJ. Lejeune F, et al. J Pharmacol Exp Ther. 1997 Mar;280(3):1241-9. J Pharmacol Exp Ther. 1997. PMID: 9067310

9

S 15535, a novel benzodioxopiperazine ligand of serotonin (5-HT)1A receptors: I. Interaction with cloned human (h)5-HT1A, dopamine hD2/hD3 and h alpha2A-adrenergic receptors in relation to modulation of cortical monoamine release and activity in models of potential antidepressant activity.

Millan MJ, Newman-Tancredi A, Rivet JM, Brocco M, Lacroix P, Audinot V, Cistarelli L, Gobert A. Millan MJ, et al. J Pharmacol Exp Ther. 1997 Jul;282(1):132-47. J Pharmacol Exp Ther. 1997. PMID: 9223549

10

S 16924 ((R)-2-[1-[2-(2,3-dihydro-benzo[1,4] dioxin-5-Yloxy)-ethyl]-pyrrolidin-3yl]-1-(4-fluoro-phenyl)-ethanone), a novel, potential antipsychotic with marked serotonin (5-HT)1A agonist properties: I. Receptorial and neurochemical profile in comparison with clozapine and haloperidol.

Millan MJ, Gobert A, Newman-Tancredi A, Audinot V, Lejeune F, Rivet JM, Cussac D, Nicolas JP, Muller O, Lavielle G. Millan MJ, et al. J Pharmacol Exp Ther. 1998 Sep;286(3):1341-55. J Pharmacol Exp Ther. 1998. PMID: 9732398

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

205 results

Search Page